Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Nevada Cancer Center
mi
from
Las Vegas, NV
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Nevada Cancer Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
East Orange VA Medical System
mi
from
East Orange, NJ
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
East Orange VA Medical System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Howell Office Plaza
mi
from
Howell, NJ
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Howell Office Plaza
mi
from
Howell, NJ
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Atlantic Hem Onc Associates, LLC
mi
from
Manasquan, NJ
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Atlantic Hem Onc Associates, LLC
mi
from
Manasquan, NJ
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Hematology/Oncology Assoc. of South Jersey
mi
from
Mount Holly, NJ
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Hematology/Oncology Assoc. of South Jersey
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Cancer Institute of New Jersey at Cooper University Hospital
mi
from
Voorhees, NJ
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Cancer Institute of New Jersey at Cooper University Hospital
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
New Mexico Oncology Hematology Consultants
mi
from
Albuquerque, NM
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
New Mexico Oncology Hematology Consultants
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
San Juan Regional Cancer Center
mi
from
Farmington, NM
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
San Juan Regional Cancer Center
mi
from
Farmington, NM
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Engracio Cortes, MD
mi
from
Bayside, NY
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Engracio Cortes, MD
mi
from
Bayside, NY
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Arena Oncology Assoc.
mi
from
Great Neck, NY
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Arena Oncology Assoc.
mi
from
Great Neck, NY
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
James P. Wilmot Cancer Center
mi
from
Rochester, NY
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
James P. Wilmot Cancer Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Syracuse VA Medical Center
mi
from
Syracuse, NY
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Syracuse VA Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Presbyterian Hospital
mi
from
Charlotte, NC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Presbyterian Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Southern Oncology Research
mi
from
Grifton, NC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Southern Oncology Research
mi
from
Grifton, NC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Barberton Citizens Hospital-Cancer Center
mi
from
Barberton, OH
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Barberton Citizens Hospital-Cancer Center
mi
from
Barberton, OH
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Dayton Clinical Oncology Program
mi
from
Dayton, OH
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Dayton Clinical Oncology Program
mi
from
Dayton, OH
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Forum Health Cancer CareCenter
mi
from
Youngstown, OH
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Forum Health Cancer CareCenter
mi
from
Youngstown, OH
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Cancer Specialists Of Oklahoma
mi
from
Oklahoma City, OK
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Cancer Specialists Of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Hematology Oncology Associates
mi
from
Medford, OR
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Hematology Oncology Associates
mi
from
Medford, OR
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Charleston Hematology Oncology, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Charleston Cancer Center
mi
from
Charleston, SC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Charleston Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Liberty Hematology Oncology
mi
from
Columbia, SC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Liberty Hematology Oncology
mi
from
Columbia, SC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Santee Hematology Oncology, Inc.
mi
from
Sumter, SC
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Santee Hematology Oncology, Inc.
mi
from
Sumter, SC
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
The Jones Clinic, PC
mi
from
Germantown, TN
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
The Jones Clinic, PC
mi
from
Germantown, TN
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Knoxville Cancer Center
mi
from
Knoxville, TN
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Knoxville Cancer Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Cancer Specialists Of South Texas, Pa
mi
from
Corpus Christi, TX
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Cancer Specialists Of South Texas, Pa
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Blood And Cancer Center of East Texas
mi
from
Tyler, TX
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Blood And Cancer Center of East Texas
mi
from
Tyler, TX
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Tyler Hematology Oncology PA
mi
from
Tyler, TX
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Tyler Hematology Oncology PA
mi
from
Tyler, TX
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Odyssey Research
mi
from
Belle Haven, VA
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Odyssey Research
mi
from
Belle Haven, VA
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
Masoom Kandahari, MD, PC
mi
from
Woodbridge, VA
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
Masoom Kandahari, MD, PC
mi
from
Woodbridge, VA
Click here to add this to my saved trials
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated:  9/12/2017
West Virginia University
mi
from
Morgantown, WV
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Status: Enrolling
Updated: 9/12/2017
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting
Status: Enrolling
Updated:  9/14/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
BATTLE-FL: A Biomarker-Integrated Study in Patients With Advanced Non-Small Cell Lung Cancer Treated in the Front-Line (FL) Setting
Status: Enrolling
Updated: 9/14/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated:  9/14/2017
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated: 9/14/2017
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated:  9/14/2017
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated: 9/14/2017
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated:  9/14/2017
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated: 9/14/2017
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated:  9/14/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated: 9/14/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated:  9/14/2017
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer
Status: Enrolling
Updated: 9/14/2017
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated:  9/14/2017
Rush University Medical Center
mi
from
Chicago, IL
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated: 9/14/2017
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated:  9/14/2017
University of Michigan
mi
from
Ann Arbor, MI
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated: 9/14/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated:  9/14/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated: 9/14/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated:  9/14/2017
Cleveland Clinic
mi
from
Cleveland, OH
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated: 9/14/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated:  9/14/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy
Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients
Status: Enrolling
Updated: 9/14/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated:  9/14/2017
Memorial Regional Hospital
mi
from
Hollywood, FL
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated: 9/14/2017
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated:  9/14/2017
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy
Status: Enrolling
Updated: 9/14/2017
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated:  9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated: 9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Teramana Cancer Center - Steubenville
mi
from
Steubenville, OH
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Teramana Cancer Center - Steubenville
mi
from
Steubenville, OH
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Beaver
mi
from
Beaver, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Beaver
mi
from
Beaver, PA
Click here to add this to my saved trials
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2017
UPMC Cancer Center - Clairton
mi
from
Clairton, PA
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2017
UPMC Cancer Center - Clairton
mi
from
Clairton, PA
Click here to add this to my saved trials